Pacific Biosciences Of California PE Ratio 2009-2020 | PACB

Current and historical p/e ratio for Pacific Biosciences Of California (PACB) from 2009 to 2020. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Pacific Biosciences Of California PE ratio as of July 10, 2020 is 0.00.
Pacific Biosciences Of California PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-07-10 3.72 0.00
2020-03-31 3.06 $-0.34 0.00
2019-12-31 5.14 $-0.55 0.00
2019-09-30 5.16 $-0.76 0.00
2019-06-30 6.05 $-0.76 0.00
2019-03-31 7.23 $-0.77 0.00
2018-12-31 7.40 $-0.77 0.00
2018-09-30 5.41 $-0.74 0.00
2018-06-30 3.55 $-0.74 0.00
2018-03-31 2.05 $-0.83 0.00
2017-12-31 2.64 $-0.89 0.00
2017-09-30 5.25 $-0.92 0.00
2017-06-30 3.56 $-0.92 0.00
2017-03-31 5.17 $-0.87 0.00
2016-12-31 3.80 $-0.84 0.00
2016-09-30 8.96 $-0.65 0.00
2016-06-30 7.04 $-0.44 0.00
2016-03-31 8.50 $-0.39 0.00
2015-12-31 13.13 $-0.43 0.00
2015-09-30 3.66 $-0.67 0.00
2015-06-30 5.76 $-0.82 0.00
2015-03-31 5.84 $-0.93 0.00
2014-12-31 7.84 $-0.94 0.00
2014-09-30 4.91 $-0.94 0.00
2014-06-30 6.18 $-1.12 0.00
2014-03-31 5.35 $-1.18 0.00
2013-12-31 5.23 $-1.27 0.00
2013-09-30 5.52 $-1.40 0.00
2013-06-30 2.53 $-1.50 0.00
2013-03-31 2.49 $-1.57 0.00
2012-12-31 1.70 $-1.70 0.00
2012-09-30 1.83 $-1.73 0.00
2012-06-30 2.17 $-1.86 0.00
2012-03-31 3.42 $-1.88 0.00
2011-12-31 2.80 $-2.04 0.00
2011-09-30 3.21 $-2.59 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.593B $0.091B
Pacific Biosciences of California, Inc. is engaged in the development, manufacture and commercialization of its single molecule, real-time, or SMRT technology-an integrated platform for genetic analysis. The SMRT technology uses the natural processing power of enzymes, combined with specially designed reagents and detection systems, to record individual biochemical events as they occur. The Company's technology platform comprises of the SMRT cells, Phospholinked nucleotides and the PacBio RS (an instrument that conducts, monitors and analyzes single molecule biochemical reactions in real time). Its product will find its application in both research institutions and commercial companies, including genome centers, government and academic institutions, genomic service providers, pharmaceutical companies and agriculture companies. Pacific Biosciences of California, Inc. is headquartered in Menlo Park, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $153.111B 31.09
Intuitive Surgical (ISRG) United States $66.993B 49.48
Edwards Lifesciences (EW) United States $42.298B 35.55
DexCom (DXCM) United States $40.678B 189.87
IDEXX Laboratories (IDXX) United States $28.977B 68.23
ALCON INC (ALC) Switzerland $27.769B 31.08
Fresenius Medical Care AG KGaA (FMS) Germany $25.274B 17.22
Olympus (OCPNY) Japan $25.082B 51.01
Teleflex (TFX) United States $16.572B 30.69
Sysmex ADR (SSMXY) Japan $15.561B 43.86
Hologic (HOLX) United States $14.839B 23.36
SONOVA HOLDING (SONVY) Switzerland $13.792B 0.00
Masimo (MASI) United States $12.797B 69.55
STERIS (STE) Ireland $12.780B 26.67
ABIOMED (ABMD) United States $11.967B 64.17
Varian Medical Systems (VAR) United States $10.761B 26.10
SARTORIUS AG (SARTF) Germany $9.169B 78.82
Penumbra (PEN) United States $6.789B 261.57
Tandem Diabetes Care (TNDM) United States $6.257B 0.00
Globus Medical (GMED) United States $4.445B 28.13
Integra LifeSciences Holdings (IART) United States $3.931B 18.03
Nevro (NVRO) United States $3.896B 0.00
Wright Medical Group (WMGI) Netherlands $3.824B 593.40
Elekta AB (EKTAY) Sweden $3.557B 27.38
Nihon Kohden (NHNKY) Japan $2.694B 0.00
OPKO Health (OPK) United States $2.693B 0.00
LivaNova (LIVN) United Kingdom $2.503B 18.87
Integer Holdings (ITGR) United States $2.189B 13.52
Cantel Medical (CMD) United States $1.825B 21.12
Glaukos (GKOS) United States $1.656B 0.00
Luminex (LMNX) United States $1.528B 0.00
Veracyte (VCYT) United States $1.479B 0.00
Silk Road Medical (SILK) United States $1.438B 0.00
ShockWave Medical (SWAV) United States $1.401B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.369B 26.55
GenMark Diagnostics (GNMK) United States $1.157B 0.00
Mesa Laboratories (MLAB) United States $0.959B 50.73
Accelerate Diagnostics (AXDX) United States $0.917B 0.00
Inogen (INGN) United States $0.768B 45.84
OrthoPediatrics (KIDS) United States $0.754B 0.00
Tactile Systems Technology (TCMD) United States $0.706B 89.58
Natus Medical (NTUS) United States $0.701B 17.29
CryoLife (CRY) United States $0.689B 96.11
Quotient (QTNT) Switzerland $0.616B 0.00
Intersect ENT (XENT) United States $0.593B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.570B 23.01
Si-Bone (SIBN) United States $0.446B 0.00
AxoGen (AXGN) United States $0.438B 0.00
Fluidigm (FLDM) United States $0.390B 0.00
Repro-Med Systems (KRMD) United States $0.387B 297.00
TransMedics (TMDX) United States $0.374B 0.00
AngioDynamics (ANGO) United States $0.365B 24.27
Oxford Immunotec Global (OXFD) United Kingdom $0.355B 0.00
Vermillion (AWH) United States $0.345B 0.00
ViewRay (VRAY) United States $0.326B 0.00
Stereotaxis (STXS) United States $0.291B 0.00
Semler Scientific (SMLR) United States $0.289B 31.88
Alphatec Holdings (ATEC) United States $0.284B 0.00
IRadimed (IRMD) United States $0.283B 30.51
SeaSpine Holdings (SPNE) United States $0.247B 0.00
RTI Surgical (RTIX) United States $0.205B 0.00
Sientra (SIEN) United States $0.198B 0.00
Accuray (ARAY) United States $0.179B 0.00
T2 Biosystems (TTOO) United States $0.160B 0.00
CRH Medical (CRHM) Canada $0.157B 110.00
Electromed (ELMD) United States $0.131B 33.67
Restoration Robotics (VERO) Canada $0.095B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.094B 0.00
Spectral Diagnostics (EDTXF) Canada $0.087B 0.00
EDAP TMS S.A (EDAP) France $0.071B 35.14
ConforMIS (CFMS) United States $0.058B 0.00
Ekso Bionics Holdings (EKSO) United States $0.056B 0.00
Bioanalytical Systems (BASI) United States $0.053B 0.00
MRI Interventions (CLPT) United States $0.050B 0.00
Sensus Healthcare (SRTS) United States $0.047B 0.00
Allied Healthcare Products (AHPI) United States $0.045B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.044B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.035B 0.00
Neuronetics (STIM) United States $0.034B 0.00
Apollo Endosurgery (APEN) United States $0.032B 0.00
Sunshine Heart Inc (CHFS) United States $0.027B 0.00
Neovasc (NVCN) Canada $0.027B 0.00
DarioHealth (DRIO) Israel $0.026B 0.00
Delcath Systems (DCTH) United States $0.025B 0.00
Second Sight Medical Products (EYES) United States $0.020B 0.00
Helius Medical Technologies (HSDT) United States $0.020B 0.00
ReWalk Robotics (RWLK) Israel $0.017B 0.00
TransEnterix (TRXC) United States $0.017B 0.00
ENDRA Life Sciences (NDRA) United States $0.013B 0.00
Xtant Medical Holdings (XTNT) United States $0.012B 0.00
Dynatronics (DYNT) United States $0.011B 0.00
Lianluo Smart (LLIT) China $0.011B 0.00
American Shared Hospital Services (AMS) United States $0.011B 39.60
Avinger (AVGR) United States $0.011B 0.00
Viveve Medical (VIVE) United States $0.009B 0.00
Nanovibronix (NAOV) United States $0.008B 0.00
Ra Medical Systems (RMED) United States $0.006B 0.00
OBALON THERPTCS (OBLN) United States $0.005B 0.00
InspireMD (NSPR) Israel $0.002B 0.00